Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Common Equity (2018 - 2025)

Verastem (VSTM) has 8 years of Common Equity data on record, last reported at $57.2 million in Q4 2025.

  • For Q4 2025, Common Equity rose 297.96% year-over-year to $57.2 million; the TTM value through Dec 2025 reached $57.2 million, up 297.96%, while the annual FY2025 figure was $57.2 million, 297.96% up from the prior year.
  • Common Equity reached $57.2 million in Q4 2025 per VSTM's latest filing, up from -$15.5 million in the prior quarter.
  • Across five years, Common Equity topped out at $102.6 million in Q1 2021 and bottomed at -$32.4 million in Q1 2025.
  • Average Common Equity over 5 years is $47.9 million, with a median of $55.5 million recorded in 2022.
  • The widest YoY moves for Common Equity: up 297.96% in 2025, down 240.38% in 2025.
  • A 5-year view of Common Equity shows it stood at $87.6 million in 2021, then plummeted by 45.88% to $47.4 million in 2022, then increased by 21.07% to $57.4 million in 2023, then tumbled by 150.36% to -$28.9 million in 2024, then skyrocketed by 297.96% to $57.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $57.2 million in Q4 2025, -$15.5 million in Q3 2025, and $36.1 million in Q2 2025.